|
業務類別
|
Biotechnology |
|
業務概覽
|
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications. |
| 公司地址
| 150 W 4th Avenue, Vancouver, BC, CAN, V5Y 1G6 |
| 電話號碼
| +1 604 559-9005 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.abcellera.com |
| 員工數量
| 562 |
| Dr. Carl L.G. Hansen, PhD |
Chairman of the Board, President and Chief Executive Officer |
美元 550.00K |
29/04/2026 |
| Mr. Andrew Booth |
Chief Financial Officer and Principal Accounting Officer |
美元 485.00K |
29/04/2026 |
| Dr. Veronique Lecault, PhD |
Chief Technology Officer and Director |
美元 454.00K |
29/04/2026 |
| Mr. Tryn Stimart |
Chief Legal Officer, Chief Compliance Officer, Corporate Secretary and Privacy Officer |
美元 470.00K |
29/04/2026 |
|
|
| Dr. Michael Hayden, M.D.,PhD |
Lead Independent Director |
29/04/2026 |
| Mr. John S. Montalbano, C.F.A. |
Independent Director |
29/04/2026 |
| Dr. Carl L.G. Hansen, PhD |
Chairman of the Board, President and Chief Executive Officer |
29/04/2026 |
| Dr. Veronique Lecault, PhD |
Chief Technology Officer and Director |
29/04/2026 |
| Dr. Stephen R. Quake, D.Phil. |
Independent Director |
29/04/2026 |
|
|
|
|
